234 related articles for article (PubMed ID: 31496729)
1. Oxymatrine reverses epithelial-mesenchymal transition in breast cancer cells by depressing α
Chen Y; Chen L; Zhang JY; Chen ZY; Liu TT; Zhang YY; Fu LY; Fan SQ; Zhang MQ; Gan SQ; Zhang NL; Shen XC
Onco Targets Ther; 2019; 12():6253-6265. PubMed ID: 31496729
[TBL] [Abstract][Full Text] [Related]
2. 14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling.
Luo J; Yao JF; Deng XF; Zheng XD; Jia M; Wang YQ; Huang Y; Zhu JH
J Exp Clin Cancer Res; 2018 Feb; 37(1):23. PubMed ID: 29426357
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
[TBL] [Abstract][Full Text] [Related]
4. Black rice-derived anthocyanins inhibit HER-2-positive breast cancer epithelial-mesenchymal transition-mediated metastasis in vitro by suppressing FAK signaling.
Zhou J; Zhu YF; Chen XY; Han B; Li F; Chen JY; Peng XL; Luo LP; Chen W; Yu XP
Int J Mol Med; 2017 Dec; 40(6):1649-1656. PubMed ID: 29039492
[TBL] [Abstract][Full Text] [Related]
5. A diterpenoid compound, excisanin A, inhibits the invasive behavior of breast cancer cells by modulating the integrin β1/FAK/PI3K/AKT/β-catenin signaling.
Qin J; Tang J; Jiao L; Ji J; Chen WD; Feng GK; Gao YH; Zhu XF; Deng R
Life Sci; 2013 Nov; 93(18-19):655-63. PubMed ID: 24044886
[TBL] [Abstract][Full Text] [Related]
6. Oxymatrine inhibits epithelial-mesenchymal transition through regulation of NF-κB signaling in colorectal cancer cells.
Liang L; Huang J
Oncol Rep; 2016 Sep; 36(3):1333-8. PubMed ID: 27430890
[TBL] [Abstract][Full Text] [Related]
7. Twist induces epithelial-mesenchymal transition and cell motility in breast cancer via ITGB1-FAK/ILK signaling axis and its associated downstream network.
Yang J; Hou Y; Zhou M; Wen S; Zhou J; Xu L; Tang X; Du YE; Hu P; Liu M
Int J Biochem Cell Biol; 2016 Feb; 71():62-71. PubMed ID: 26693891
[TBL] [Abstract][Full Text] [Related]
8. Effecacy of Biejia (Carapax Trionycis) and Ezhu (Rhizoma Curcumae Phaeocaulis) couplet medicine on epithelial-mesenchymal transition, invasion and migration of MDA-MB-231 triple negative breast cancer cells via PI3K/Akt/mTOR signaling pathway.
Zhu MJ; Xie S; Xie Q; Zhu JL; Huang YZ
J Tradit Chin Med; 2021 Dec; 41(6):853-861. PubMed ID: 34939381
[TBL] [Abstract][Full Text] [Related]
9. The anti-migration and anti-invasion effects of Bruceine D in human triple-negative breast cancer MDA-MB-231 cells.
Luo C; Wang Y; Wei C; Chen Y; Ji Z
Exp Ther Med; 2020 Jan; 19(1):273-279. PubMed ID: 31853299
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Matrix Derived from High Metastatic Human Breast Cancer Triggers Epithelial-Mesenchymal Transition in Epithelial Breast Cancer Cells through αvβ3 Integrin.
M Brandão-Costa R; Helal-Neto E; M Vieira A; Barcellos-de-Souza P; Morgado-Diaz J; Barja-Fidalgo C
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340328
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer.
Wang JR; Liu B; Zhou L; Huang YX
Cancer Biomark; 2019; 24(2):159-172. PubMed ID: 30614803
[TBL] [Abstract][Full Text] [Related]
12. Potential function of oxymatrine as a novel suppressor of epithelial-to-mesenchymal transition in lung tumor cells.
Jung YY; Baek SH; Narula AS; Namjoshi OA; Blough BE; Ahn KS
Life Sci; 2021 Nov; 284():119893. PubMed ID: 34454947
[TBL] [Abstract][Full Text] [Related]
13. A ROS/Akt/NF-κB Signaling Cascade Mediates Epidermal Growth Factor-Induced Epithelial-Mesenchymal Transition and Invasion in Human Breast Cancer Cells.
Min WL; Wang BF; Liang BB; Zhang L; Pan JY; Huang Y; Zhao Y; Lin S; Zhao YH; Zhang SQ; Ma QY
World J Oncol; 2022 Oct; 13(5):289-298. PubMed ID: 36406192
[TBL] [Abstract][Full Text] [Related]
14. Pristimerin exerts antitumor activity against MDA-MB-231 triple-negative breast cancer cells by reversing of epithelial-mesenchymal transition via downregulation of integrin β3.
Liu S; Dong Y; Wang Y; Hu P; Wang J; Wang RY
Biomed J; 2021 Dec; 44(6 Suppl 1):S84-S92. PubMed ID: 35652598
[TBL] [Abstract][Full Text] [Related]
15. DS-1 Inhibits Migration and Invasion of Non-small-cell Lung Cancer Cells Through Suppression of Epithelial to Mesenchymal Transition and Integrin β1/FAK Signaling.
Putri HE; Sritularak B; Chanvorachote P
Anticancer Res; 2021 Jun; 41(6):2913-2923. PubMed ID: 34083282
[TBL] [Abstract][Full Text] [Related]
16. Oxymatrine reverses 5-fluorouracil resistance by inhibition of colon cancer cell epithelial-mesenchymal transition and NF-κB signaling
Liang L; Wu J; Luo J; Wang L; Chen ZX; Han CL; Gan TQ; Huang JA; Cai ZW
Oncol Lett; 2020 Jan; 19(1):519-526. PubMed ID: 31897166
[TBL] [Abstract][Full Text] [Related]
17. EGF induces epithelial-mesenchymal transition through phospho-Smad2/3-Snail signaling pathway in breast cancer cells.
Kim J; Kong J; Chang H; Kim H; Kim A
Oncotarget; 2016 Dec; 7(51):85021-85032. PubMed ID: 27829223
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis.
Wendt MK; Schiemann WP
Breast Cancer Res; 2009; 11(5):R68. PubMed ID: 19740433
[TBL] [Abstract][Full Text] [Related]
19. Shikonin inhibits triple-negative breast cancer-cell metastasis by reversing the epithelial-to-mesenchymal transition via glycogen synthase kinase 3β-regulated suppression of β-catenin signaling.
Chen Y; Chen ZY; Chen L; Zhang JY; Fu LY; Tao L; Zhang Y; Hu XX; Shen XC
Biochem Pharmacol; 2019 Aug; 166():33-45. PubMed ID: 31071331
[TBL] [Abstract][Full Text] [Related]
20. Daidzin targets epithelial-to-mesenchymal transition process by attenuating manganese superoxide dismutase expression and PI3K/Akt/mTOR activation in tumor cells.
Yang MH; Jung SH; Um JY; Kumar AP; Sethi G; Ahn KS
Life Sci; 2022 Apr; 295():120395. PubMed ID: 35181309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
